Research
Hormonal
Combination strategies using endoscopic bariatric therapies (EBTs) and anti-obesity medications (AOMs) result in greater total-body weight loss than either modality alone.
Combining EBTs with AOMs may enhance weight loss outcomes for patients.
StrongSupportsmedium confidence
Combination strategies using EBTs and anti-obesity medications (AOMs), particularly GLP-1 receptor agonists, have resulted in greater total-body weight loss than either modality alone.
Why this rating
The claim is based on a review of established therapies.
Source
Emerging Trends in Endoscopic Bariatric Therapies: Personalization Through Genomics and Synergistic Pharmacotherapy
Wissam Ghusn et al. · Journal of Clinical Medicine · 2025
reviewCited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →